Yerly S - Search Results

1

Increasing Frequency and Transmission of HIV-1 Non-B Subtypes Among Men Who Have Sex With Men in the Swiss HIV Cohort Study.

Duran Ramirez JJ, Ballouz T, Nguyen H, Kusejko K, Chaudron SE, Huber M, Hirsch HH, Perreau M, Ramette A, Yerly S, Cavassini M, Stöckle M, Furrer H, Vernazza P, Bernasconi E, Günthard HF, Kouyos RD; Swiss HIV Cohort Study. Duran Ramirez JJ, et al. Among authors: yerly s. J Infect Dis. 2022 Jan 18;225(2):306-316. doi: 10.1093/infdis/jiab360. J Infect Dis. 2022. PMID: 34260728 Free article.

2

Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters.

Yerly S, Chamot E, Hirschel B, Perrin LH. Yerly S, et al. J Infect Dis. 1992 Aug;166(2):269-76. doi: 10.1093/infdis/166.2.269. J Infect Dis. 1992. PMID: 1353103

3

Absence of chronic human immunodeficiency virus infection without seroconversion in intravenous drug users: a prospective and retrospective study.

Yerly S, Chamot E, Déglon JJ, Hirschel B, Perrin LH. Yerly S, et al. J Infect Dis. 1991 Nov;164(5):965-8. doi: 10.1093/infdis/164.5.965. J Infect Dis. 1991. PMID: 1940476

4

Response of HIV RNA to didanosine as a predictive marker of survival.

Yerly S, Kaiser L, Mermillod B, Baumberger C, Hirschel B, Perrin L. Yerly S, et al. AIDS. 1995 Feb;9(2):159-63. AIDS. 1995. PMID: 7718186

5

Foscarnet decreases human immunodeficiency virus RNA.

Kaiser L, Perrin L, Hirschel B, Furrer H, Von Overbeck J, Olmari M, Yerly S. Kaiser L, et al. Among authors: yerly s. J Infect Dis. 1995 Jul;172(1):225-7. doi: 10.1093/infdis/172.1.225. J Infect Dis. 1995. PMID: 7797916 Clinical Trial.

6

Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.

Yerly S, Kaiser L, Baumberger C, Hirschel B, Perrin LH. Yerly S, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 1;8(4):358-64. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7882100

7

Mother to child transmission of zidovudine-resistant HIV-1.

Siegrist CA, Yerly S, Kaiser L, Wyler CA, Perrin L. Siegrist CA, et al. Among authors: yerly s. Lancet. 1994 Dec 24-31;344(8939-8940):1771-2. Lancet. 1994. PMID: 7997023 No abstract available.

8

Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group.

Galetto-Lacour A, Yerly S, Perneger TV, Baumberger C, Hirschel B, Perrin L. Galetto-Lacour A, et al. Among authors: yerly s. J Infect Dis. 1996 Jun;173(6):1388-93. doi: 10.1093/infdis/173.6.1388. J Infect Dis. 1996. PMID: 8648210

9

A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study.

Yerly S, Perneger TV, Hirschel B, Dubuis O, Matter L, Malinverni R, Furrer H, Perrin L. Yerly S, et al. Arch Intern Med. 1998 Feb 9;158(3):247-52. doi: 10.1001/archinte.158.3.247. Arch Intern Med. 1998. PMID: 9472204

10

Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy.

Perrin L, Yerly S, Marchal F, Schockmel GA, Hirschel B, Fox CH, Pantaleo G. Perrin L, et al. Among authors: yerly s. J Infect Dis. 1998 Jun;177(6):1497-501. doi: 10.1086/515303. J Infect Dis. 1998. PMID: 9607825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters